OVERVIEW

An American Journal of Managed Care® Symposium: Living With Psoriatic Disease is organized by Pharmacy Times Continuing Education (PTCE). This activity is approved for 1.5 contact hour (0.15 CEU).

Dates:
Release Date: January 20, 2020
Expiration Date: November 8, 2020

Activity Overview:
A greater understanding of the immunologic, genetic, and autoimmune characteristics of psoriasis (PsO) has improved substantially in the past decade. PsO is more than a dermatologic condition; patients with severe disease have a higher mortality rate with a 50% greater risk of premature death, most likely due to the presence of comorbidities. Managed care professionals, pharmacy benefit managers, and specialty pharmacists should be familiar with the economic burden associated with PsO and psoriatic arthritis (PsA), the associated comorbidities, the importance of early intervention, and the availability of newer biologics and emerging agents in the treatment and management of these diseases. This session will highlight important ways to consider the effectiveness and cost-efficacy data along with patients’ preferences and disease severity in ascertaining how to optimize care for patients with PsO and PsA.

Educational Objectives:
• Explore the clinical and societal challenges of patients with psoriatic disease
• Identify patients who may benefit from early and aggressive treatment
• Analyze the most recent clinical data to treat psoriatic disease
• Examine the role of the managed care professional in appropriate patient selection and optimization of cost and outcomes

Additional details will be posted as soon as information is available.